All News

BALTIMORE -- Patients with internal carotid artery stenosis may be undergoing needless tests and interventions, investigators reported here.

CHICAGO -- African Americans with metastatic colorectal cancer do not fare as well as Caucasians when bevacizumab (Avastin) is added to the FOLFOX regimen, investigators reported here.

CHICAGO -- Confirming results of earlier studies, pemetrexed combined with either cisplatin or carboplatin demonstrated activity in previously untreated malignant pleural mesothelioma, said researchers here.

BOSTON -- Decline in renal function associated with Amyloid A (AA) amyloidosis can be slowed by eprodisate (Kiacta), a drug that inhibits the deposit of the complex protein in tissues.

CHICAGO -- An investigational immunotherapy that targets an antigen produced by non-small-cell lung cancer (NSCLC) tended to reduce the risk of recurrence by 27% when used as adjuvant therapy with surgery.

TURIN, Italy -- Mitotane (Lysodren), a controversial derivative of the insecticide DDT, extends relapse-free survival in cases of radically resected adrenocortical carcinoma, researchers here say.

SALT LAKE CITY -- Few hotels, motels, and resorts have installed carbon monoxide detectors despite nearly 800 cases of poisonings over 15 years, according to researchers here.

DURHAM, N.C. -- Rewarding hospitals by paying them for performance may be ill-spent money, researchers here found, citing no significant difference in acute MI outcomes between hospitals in a Medicare incentive program and those that were not.

CHICAGO -- An updated and expanded meta-analysis has reinforced the survival advantage conferred by adjuvant chemotherapy in non-small-cell lung cancer, first hinted at 12 years ago.

NASHVILLE -- Researchers here say they've found a way to tell which lung cancer patients will benefit from new targeted -- and expensive --therapies.

CHICAGO -- Pemetrexed (Alimta) plus platinum chemotherapy for advanced non-small cell lung cancer (NSCLC) may reduce toxicity compared with a gemcitabine (Gemzar) and platinum doublet but hold little other advantage.

CHICAGO -- A shorter lead-in time between recommended vitamin B12 supplementation and pemetrexed (Alimta) therapy may reduce treatment delays without impairing its efficacy.

PHILADELPHIA -- Magnets and batteries may cause serious harm if swallowed, necessitating endoscopic or surgical removal.

PHILADELPHIA -- An average of 15 in-flight medical emergencies happen on domestic flights every day in the United States, according to estimates from the Federal Aviation Administration (FAA).

SAN DIEGO -- Men older than 50 with androgen deficiency are at a greater risk for all-cause mortality than their peers with age-appropriate testosterone, reported investigators here.

CHICAGO, June 5 -- Targeted therapy missed the mark as maintenance therapy for small-cell lung cancer, researchers reported here.

CHICAGO -- Cetuximab (Erbitux) added to first-line chemotherapy for metastatic colorectal cancer lengthens progression-free survival by about a month, researchers found.

CHICAGO -- Recurrence rates for resectable liver metastases from colorectal cancer are lower when adjuvant and neoadjuvant chemotherapy augment surgery, researchers said here.